271 related articles for article (PubMed ID: 18793395)
1. The impact of functional imaging on radiation medicine.
Sharma N; Neumann D; Macklis R
Radiat Oncol; 2008 Sep; 3():25. PubMed ID: 18793395
[TBL] [Abstract][Full Text] [Related]
2. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
3. RT_Image: an open-source tool for investigating PET in radiation oncology.
Graves EE; Quon A; Loo BW
Technol Cancer Res Treat; 2007 Apr; 6(2):111-21. PubMed ID: 17375973
[TBL] [Abstract][Full Text] [Related]
4. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
5. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
Sager O; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Elcim Y; Gundem E; Dirican B; Beyzadeoglu M
Curr Radiopharm; 2019; 12(1):4-10. PubMed ID: 30465520
[TBL] [Abstract][Full Text] [Related]
6. Recent advances of PET imaging in clinical radiation oncology.
Unterrainer M; Eze C; Ilhan H; Marschner S; Roengvoraphoj O; Schmidt-Hegemann NS; Walter F; Kunz WG; Rosenschöld PMA; Jeraj R; Albert NL; Grosu AL; Niyazi M; Bartenstein P; Belka C
Radiat Oncol; 2020 Apr; 15(1):88. PubMed ID: 32317029
[TBL] [Abstract][Full Text] [Related]
7. Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists.
Shakespeare TP
Radiat Oncol; 2015 Nov; 10():233. PubMed ID: 26582424
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
J Nucl Med; 2010 Mar; 51(3):401-12. PubMed ID: 20150250
[TBL] [Abstract][Full Text] [Related]
9. Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology.
Verma V; Choi JI; Sawant A; Gullapalli RP; Chen W; Alavi A; Simone CB
Semin Radiat Oncol; 2018 Jun; 28(3):171-177. PubMed ID: 29933876
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia PET/CT imaging: implications for radiation oncology.
Arabi M; Piert M
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):500-9. PubMed ID: 20927017
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
12. Advanced Functional Tumor Imaging and Precision Nuclear Medicine Enabled by Digital PET Technologies.
Wright CL; Binzel K; Zhang J; Knopp MV
Contrast Media Mol Imaging; 2017; 2017():5260305. PubMed ID: 29097926
[TBL] [Abstract][Full Text] [Related]
13. Biological imaging for individualized therapy in radiation oncology: part II medical and clinical aspects.
Gkika E; Oehlke O; Bunea H; Wiedenmann N; Adebahr S; Nestle U; Zamboglou C; Kirste S; Fennell J; Brunner T; Gainey M; Baltas D; Langer M; Urbach H; Bock M; Meyer PT; Grosu AL
Future Oncol; 2018 Apr; 14(8):751-769. PubMed ID: 29521519
[TBL] [Abstract][Full Text] [Related]
14. Dynamic threshold for radiation target volume by PET/CT.
Wong CY; Mahajan P; Yan D
J Nucl Med; 2007 May; 48(5):849; author reply 847. PubMed ID: 17475975
[No Abstract] [Full Text] [Related]
15. Principles of nuclear medicine imaging: planar, SPECT, PET, multi-modality, and autoradiography systems.
Zanzonico P
Radiat Res; 2012 Apr; 177(4):349-64. PubMed ID: 22364319
[TBL] [Abstract][Full Text] [Related]
16. PET-CT in oncology.
Purandare NC; Rangarajan V
J Postgrad Med; 2010; 56(2):103-8. PubMed ID: 20622389
[TBL] [Abstract][Full Text] [Related]
17. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response.
Heron DE; Andrade RS; Beriwal S; Smith RP
Am J Clin Oncol; 2008 Aug; 31(4):352-62. PubMed ID: 18845994
[TBL] [Abstract][Full Text] [Related]
18. [NUCLEAR MEDICINE AND MOLECULAR IMAGING: FROM BASIC SCIENCE TO THE FRONT IN INNOVATIVE IMAGING AND TREATMENT].
Hod N; Levin D; Tiktinsky K; Ezroh Katzap D; Lantsberg S
Harefuah; 2021 Jul; 160(7):448-454. PubMed ID: 34263573
[TBL] [Abstract][Full Text] [Related]
19. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
20. [Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].
Gatidis S; Gückel B; la Fougère C; Schmitt J; Schäfer JF
Radiologe; 2016 Jul; 56(7):622-30. PubMed ID: 27306199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
